person

Antonia Z.

Country
Bulgaria
Department
N/A

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 27 partner sites.

Specializations

Mood Disorders

Focuses on therapeutic strategies for Major Depressive Disorder and depressive episodes linked to Bipolar Disorder.

  • Adjunctive antidepressant therapies
  • Treatment‑resistant depression
  • Bipolar depression management
  • Insomnia comorbidity in depression
  • Novel oral agents for depression

Clinical work integrates adjunctive regimens to improve symptom control and functional outcomes.

Anxiety Disorders

Investigates adjunctive treatments for Generalized Anxiety Disorder and related anxiety conditions.

  • Flexible dosing of anxiolytics
  • HAM‑A score improvement
  • Combination therapy with SSRIs/SNRIs
  • Safety profiling of new anxiolytic agents
  • Patient‑reported anxiety outcomes

Emphasis on rapid onset of anxiolytic effect and tolerability.

Psychotic Disorders

Engages in studies of adjunctive options for Schizophrenia and psychosis associated with neurodegenerative disease.

  • Adjunctive antipsychotic strategies
  • PANSS score reduction
  • Long‑term safety of combined agents
  • Management of treatment‑resistant psychosis
  • Quality‑of‑life improvements

Research includes both chronic schizophrenia and psychosis secondary to Alzheimer’s disease.

Dementia‑Related Psychosis

Targets psychotic manifestations in Alzheimer’s disease and Lewy Body Dementia.

  • Agitation control
  • Psychosis rating scales
  • Dual‑agent adjunctive therapy
  • Safety in elderly populations
  • Reduction of hallucinations and delusions

Studies aim to balance efficacy with tolerability in frail patients.

Cerebrovascular Prevention

Evaluates antithrombotic strategies to prevent recurrent ischemic stroke after acute events.

  • Oral FXIa inhibition
  • Reduction of major bleeding risk
  • Integration with antiplatelet therapy
  • High‑risk transient ischemic attack management
  • Long‑term vascular outcomes

Focus on optimizing secondary prevention while minimizing hemorrhagic complications.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.